NICOTINE

NICOTINE was reported 40620 times

NICOTINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 187 0.6172
1 PLETHYSMOGRAPHY 16 0.6154
2 RHESUS INCOMPATIBILITY 68 0.5620
3 APPLICATION SITE BRUISING 33 0.5410
4 TOBACCO POISONING 58 0.5370
5 TRUNCUS ARTERIOSUS PERSISTENT 77 0.3869
6 NICOTINE DEPENDENCE 2758 0.3542
7 APPLICATION SITE HYPERAESTHESIA 28 0.2828
8 APPLICATION SITE DERMATITIS 248 0.2652
9 APPLICATION SITE URTICARIA 445 0.1980
10 MYOCARDIAL STUNNING 25 0.1866
11 APPLICATION SITE PERSPIRATION 30 0.1734
12 RIB DEFORMITY 44 0.1732
13 APPLICATION SITE PAPULES 183 0.1725
14 TOBACCO INTERACTION 17 0.1532
15 APPLICATION SITE PRURITUS 3080 0.1356
16 APPLICATION SITE SWELLING 659 0.1321
17 APPLICATION SITE REACTION 903 0.1283
18 APPLICATION SITE WARMTH 162 0.1270
19 TOBACCO ABUSE 67 0.1255
20 LUNG DIFFUSION DISORDER 19 0.1210
21 APPLICATION SITE ERYTHEMA 3150 0.1201
22 TOBACCO WITHDRAWAL SYMPTOMS 21 0.1200
23 FEMALE GENITAL TRACT FISTULA 191 0.1118
24 APPLICATION SITE PARAESTHESIA 118 0.0905
25 APPLICATION SITE IRRITATION 1116 0.0896
26 REVERSIBLE AIRWAYS OBSTRUCTION 43 0.0846
27 CARDIAC SEPTAL DEFECT 57 0.0793
28 ORAL MUCOSAL DISCOLOURATION 52 0.0783
29 APPLICATION SITE RASH 1050 0.0763
30 NEUTROPENIA NEONATAL 17 0.0759
31 TOOTH EROSION 91 0.0743
32 TREMOR NEONATAL 33 0.0740
33 APPLICATION SITE BLEEDING 18 0.0729
34 RADICULOPATHY 190 0.0720
35 CONGENITAL CARDIOVASCULAR ANOMALY 60 0.0715
36 MULTIPLE DRUG OVERDOSE ACCIDENTAL 32 0.0700
37 CHRONIC SINUSITIS 261 0.0695
38 MACULAR DEGENERATION 828 0.0693
39 PROCTITIS 192 0.0685
40 TOBACCO USER 98 0.0661
41 PRODUCT SELECTION ERROR 59 0.0538
42 IDIOPATHIC INTERSTITIAL PNEUMONIA 19 0.0537
43 MEDIASTINAL MASS 20 0.0522
44 JAUNDICE NEONATAL 98 0.0517
45 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19 0.0509
46 ADENOIDECTOMY 19 0.0490
47 APPLICATION SITE PAIN 1052 0.0477
48 APPLICATION SITE VESICLES 309 0.0476
49 APPLICATION SITE BRUISE 46 0.0473
50 APPLICATION SITE SCAR 59 0.0471
51 PULMONARY EOSINOPHILIA 20 0.0437
52 NECROSIS ISCHAEMIC 20 0.0434
53 RESPIRATORY GAS EXCHANGE DISORDER 16 0.0431
54 APPLICATION SITE HYPERSENSITIVITY 50 0.0412
55 INTENTIONAL DRUG MISUSE 853 0.0408
56 HICCUPS 329 0.0400
57 BREECH PRESENTATION 49 0.0389
58 APPLICATION SITE INFLAMMATION 52 0.0375
59 SUBSTANCE DEPENDENCE 25 0.0371
60 TOOTH DISCOLOURATION 108 0.0367
61 ELEVATED MOOD 16 0.0366
62 SPUTUM PURULENT 24 0.0365
63 FOETAL DISORDER 30 0.0359
64 EXPOSURE DURING BREAST FEEDING 118 0.0356
65 ABNORMAL DREAMS 969 0.0351
66 APPLICATION SITE BURN 166 0.0337
67 EXPOSURE VIA BREAST MILK 130 0.0326
68 PRODUCT ADHESION ISSUE 1118 0.0313
69 APPLICATION SITE ULCER 22 0.0311
70 APPLICATION SITE DISCOLOURATION 123 0.0302
71 DIAPHRAGMATIC DISORDER 23 0.0301
72 ORAL DISCOMFORT 418 0.0300
73 BRONCHIAL WALL THICKENING 20 0.0278
74 APPLICATION SITE DISCOMFORT 50 0.0278
75 BURN ORAL CAVITY 16 0.0278
76 GINGIVAL DISCOMFORT 18 0.0272
77 APPLICATION SITE EROSION 35 0.0272
78 DRUG WITHDRAWAL SYNDROME NEONATAL 402 0.0271
79 APPLICATION SITE SCAB 55 0.0254
80 FOETAL DISTRESS SYNDROME 54 0.0254
81 AGITATION NEONATAL 24 0.0250
82 DRUG DETOXIFICATION 22 0.0246
83 LOW BIRTH WEIGHT BABY 186 0.0234
84 NASAL OBSTRUCTION 42 0.0224
85 PARAESTHESIA ORAL 321 0.0222
86 APPLICATION SITE DRYNESS 73 0.0215
87 LIP DISCOLOURATION 27 0.0214
88 SUBSTANCE ABUSE 173 0.0212
89 PNEUMONIA STREPTOCOCCAL 23 0.0210
90 PRODUCT AFTER TASTE 20 0.0210
91 DRUG ADMINISTRATION ERROR 632 0.0206
92 CLEFT LIP 18 0.0206
93 ALCOHOL ABUSE 55 0.0205
94 PULMONARY GRANULOMA 23 0.0201
95 APPLICATION SITE DISCHARGE 23 0.0199
96 SECONDARY IMMUNODEFICIENCY 24 0.0198
97 ALCOHOL WITHDRAWAL SYNDROME 17 0.0195
98 VAGINAL DISCHARGE 197 0.0195
99 APPLICATION SITE EXFOLIATION 76 0.0184
100 PRODUCT COMPLAINT 466 0.0184
101 AXONAL NEUROPATHY 16 0.0183
102 TONGUE DISCOLOURATION 80 0.0183
103 MICROCEPHALY 23 0.0179
104 DERMATITIS CONTACT 203 0.0178
105 NIGHTMARE 614 0.0177
106 TONGUE DISCOMFORT 72 0.0169
107 DENTAL CARIES 187 0.0169
108 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 21 0.0167
109 HEART DISEASE CONGENITAL 59 0.0167
110 STOMACH DISCOMFORT 86 0.0166
111 BRONCHIAL HYPERREACTIVITY 20 0.0166
112 MULTIPLE DRUG OVERDOSE 82 0.0165
113 ORAL CANDIDIASIS 214 0.0162
114 VENTRICULAR SEPTAL DEFECT 93 0.0162
115 PREMATURE DELIVERY 258 0.0162
116 BRONCHIAL SECRETION RETENTION 20 0.0157
117 EXPIRED DRUG ADMINISTERED 75 0.0151
118 DRUG ABUSER 93 0.0151
119 ACCIDENTAL DEATH 28 0.0151
120 EXPIRED PRODUCT ADMINISTERED 494 0.0148
121 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 29 0.0147
122 CHEST X-RAY ABNORMAL 45 0.0147
123 OPHTHALMOPLEGIA 23 0.0146
124 SCHIZOAFFECTIVE DISORDER 26 0.0146
125 CARDIAC DEATH 17 0.0141
126 COUNTERFEIT PRODUCT ADMINISTERED 18 0.0138
127 ALCOHOL INTERACTION 26 0.0134
128 TREATMENT NONCOMPLIANCE 725 0.0132
129 PREMATURE SEPARATION OF PLACENTA 20 0.0130
130 NASAL OEDEMA 23 0.0127
131 TENSION 77 0.0126
132 INCORRECT DRUG ADMINISTRATION DURATION 355 0.0126
133 FEELING JITTERY 235 0.0123
134 NEPHROGENIC ANAEMIA 57 0.0123
135 PREMATURE BABY 364 0.0121
136 JAW FRACTURE 26 0.0120
137 THROAT CLEARING 45 0.0120
138 TONSILLECTOMY 20 0.0120
139 CLEFT PALATE 23 0.0119
140 EUPHORIC MOOD 120 0.0117
141 OROPHARYNGEAL BLISTERING 19 0.0116
142 OBSESSIVE THOUGHTS 21 0.0116
143 MYCOBACTERIAL INFECTION 20 0.0116
144 HYPERPARATHYROIDISM SECONDARY 29 0.0116
145 NEONATAL DISORDER 18 0.0114
146 NONSPECIFIC REACTION 62 0.0113
147 EMPHYSEMA 111 0.0110
148 INTENTIONAL MISUSE 21 0.0110
149 SENSITIVITY OF TEETH 19 0.0110
150 TONGUE BLISTERING 24 0.0108
151 APPLICATION SITE HAEMORRHAGE 29 0.0106
152 MOUTH INJURY 16 0.0105
153 RESPIRATORY DISORDER NEONATAL 17 0.0105
154 DRUG EFFECT INCREASED 32 0.0101
155 PHARYNGEAL PARAESTHESIA 16 0.0101
156 DISINHIBITION 16 0.0099
157 METHAEMOGLOBINAEMIA 23 0.0099
158 OLIGOHYDRAMNIOS 33 0.0099
159 GINGIVAL PAIN 78 0.0098
160 COMPULSIVE SHOPPING 20 0.0097
161 GAMBLING DISORDER 26 0.0096
162 GASTRIC DILATATION 16 0.0096
163 ANTIPSYCHOTIC DRUG LEVEL INCREASED 27 0.0096
164 REBOUND ACID HYPERSECRETION 29 0.0096
165 FOETAL EXPOSURE DURING PREGNANCY 777 0.0095
166 CLOSTRIDIUM TEST POSITIVE 21 0.0095
167 THROAT IRRITATION 426 0.0095
168 PHARYNGOLARYNGEAL PAIN 49 0.0092
169 FULL BLOOD COUNT ABNORMAL 95 0.0090
170 OEDEMA MOUTH 29 0.0089
171 NERVOUSNESS 457 0.0087
172 GLOSSITIS 31 0.0087
173 BODY TEMPERATURE ABNORMAL 16 0.0087
174 MATERNAL DRUGS AFFECTING FOETUS 65 0.0085
175 DRUG SCREEN POSITIVE 67 0.0085
176 GUN SHOT WOUND 16 0.0084
177 PROCEDURAL PAIN 231 0.0083
178 THERMAL BURN 59 0.0083
179 BLOOD IMMUNOGLOBULIN E INCREASED 20 0.0083
180 ALCOHOL POISONING 22 0.0082
181 FREQUENT BOWEL MOVEMENTS 221 0.0082
182 REGURGITATION 27 0.0079
183 PERIODONTITIS 17 0.0078
184 HOMICIDAL IDEATION 31 0.0076
185 OESOPHAGEAL PAIN 30 0.0076
186 PRODUCT QUALITY ISSUE 1011 0.0074
187 NASAL DISCOMFORT 59 0.0074
188 VITAMIN B12 DEFICIENCY 30 0.0074
189 ECONOMIC PROBLEM 112 0.0074
190 CAESAREAN SECTION 86 0.0074
191 AORTIC ARTERIOSCLEROSIS 19 0.0074
192 ABORTION INDUCED 69 0.0073
193 SMALL FOR DATES BABY 36 0.0072
194 PRE-ECLAMPSIA 34 0.0071
195 TOOTH FRACTURE 78 0.0071
196 PREMATURE LABOUR 40 0.0071
197 DRUG TOXICITY 96 0.0070
198 LEFT VENTRICULAR HYPERTROPHY 30 0.0070
199 METABOLIC ENCEPHALOPATHY 21 0.0070
200 SALIVARY HYPERSECRETION 70 0.0070
201 PSYCHOMOTOR HYPERACTIVITY 116 0.0070
202 OROPHARYNGEAL DISCOMFORT 63 0.0070
203 BREATH ODOUR 17 0.0070
204 ORAL PAIN 156 0.0070
205 ACCIDENTAL EXPOSURE 29 0.0070
206 BRONCHITIS CHRONIC 17 0.0070
207 PRODUCT TASTE ABNORMAL 94 0.0069
208 TOOTHACHE 124 0.0068
209 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 352 0.0067
210 ATELECTASIS 65 0.0067
211 OBSTRUCTIVE AIRWAYS DISORDER 74 0.0066
212 BRONCHIOLITIS 23 0.0065
213 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 112 0.0065
214 GINGIVAL DISORDER 25 0.0065
215 DYSPEPSIA 634 0.0064
216 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1304 0.0064
217 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 453 0.0064
218 UPPER-AIRWAY COUGH SYNDROME 52 0.0063
219 COLITIS 239 0.0063
220 RETCHING 134 0.0063
221 SUICIDAL BEHAVIOUR 26 0.0062
222 PLEURITIC PAIN 17 0.0062
223 DRUG USE DISORDER 51 0.0061
224 RECTAL HAEMORRHAGE 260 0.0060
225 UMBILICAL HERNIA 28 0.0060
226 BIPOLAR DISORDER 65 0.0060
227 IRRITABILITY 359 0.0060
228 POST-TRAUMATIC STRESS DISORDER 40 0.0060
229 NEONATAL RESPIRATORY DISTRESS SYNDROME 21 0.0059
230 GINGIVITIS 32 0.0059
231 LIP PAIN 17 0.0059
232 TONGUE ULCERATION 20 0.0059
233 INCORRECT PRODUCT ADMINISTRATION DURATION 126 0.0058
234 CHOKING SENSATION 32 0.0058
235 RED CELL DISTRIBUTION WIDTH INCREASED 24 0.0058
236 PRURITUS GENERALISED 124 0.0057
237 ANHEDONIA 150 0.0057
238 RHINITIS 46 0.0057
239 GINGIVAL SWELLING 25 0.0057
240 HYPERSENSITIVITY 1046 0.0056
241 MAJOR DEPRESSION 41 0.0056
242 HEART RATE INCREASED 555 0.0056
243 ENERGY INCREASED 33 0.0056
244 SENSATION OF FOREIGN BODY 47 0.0056
245 PATENT DUCTUS ARTERIOSUS 22 0.0055
246 DYSGEUSIA 407 0.0055
247 THROAT CANCER 23 0.0054
248 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
249 ALCOHOL USE 20 0.0054
250 SNORING 20 0.0053
251 MATERNAL EXPOSURE DURING PREGNANCY 470 0.0053
252 PANIC REACTION 38 0.0053
253 END STAGE RENAL DISEASE 96 0.0053
254 PRIAPISM 18 0.0052
255 FOETAL GROWTH RESTRICTION 31 0.0051
256 DRUG ABUSE 423 0.0051
257 INTENTIONAL UNDERDOSE 37 0.0051
258 SPUTUM DISCOLOURED 48 0.0051
259 OVERDOSE 1089 0.0050
260 SELF-INJURIOUS IDEATION 21 0.0050
261 DRUG EFFECT LESS THAN EXPECTED 74 0.0050
262 POOR QUALITY DRUG ADMINISTERED 32 0.0049
263 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
264 FORMICATION 34 0.0049
265 COLITIS ULCERATIVE 218 0.0049
266 GLOSSODYNIA 109 0.0049
267 TRANSFUSION 51 0.0049
268 PALPITATIONS 566 0.0048
269 POOR QUALITY SLEEP 104 0.0048
270 SKIN ODOUR ABNORMAL 19 0.0048
271 PHARYNGEAL OEDEMA 74 0.0048
272 MATERNAL EXPOSURE DURING BREAST FEEDING 19 0.0047
273 PRODUCT COLOUR ISSUE 24 0.0047
274 ALCOHOLISM 20 0.0047
275 NASAL POLYPS 23 0.0047
276 COLD SWEAT 82 0.0046
277 MUSCULOSKELETAL CHEST PAIN 72 0.0046
278 SINUS TACHYCARDIA 66 0.0046
279 WITHDRAWAL SYNDROME 194 0.0046
280 RESTLESSNESS 166 0.0045
281 ANGER 152 0.0045
282 OBSESSIVE-COMPULSIVE DISORDER 36 0.0045
283 POOR QUALITY PRODUCT ADMINISTERED 47 0.0045
284 FACIAL BONES FRACTURE 16 0.0044
285 SENSATION OF HEAVINESS 17 0.0044
286 DRUG TOLERANCE 22 0.0043
287 HYPERVENTILATION 25 0.0043
288 INCREASED APPETITE 82 0.0043
289 ARTERIOSCLEROSIS 40 0.0042
290 ORAL DISORDER 31 0.0042
291 CHRONIC KIDNEY DISEASE 320 0.0042
292 TROPONIN INCREASED 32 0.0042
293 PRODUCT ADMINISTRATION INTERRUPTED 33 0.0042
294 HAEMATOCHEZIA 232 0.0042
295 INSOMNIA 1118 0.0042
296 PRE-EXISTING CONDITION IMPROVED 26 0.0042
297 PULMONARY MASS 62 0.0042
298 NAUSEA 3290 0.0042
299 HALLUCINATION, AUDITORY 66 0.0041
300 WHEEZING 246 0.0041
301 SNEEZING 93 0.0041
302 ACCIDENTAL OVERDOSE 150 0.0041
303 HYPERLIPIDAEMIA 49 0.0041
304 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
305 EOSINOPHIL COUNT INCREASED 34 0.0041
306 PANIC ATTACK 147 0.0040
307 DRUG INEFFECTIVE 5305 0.0040
308 OSTEOPENIA 61 0.0040
309 TONGUE DISORDER 29 0.0040
310 INITIAL INSOMNIA 41 0.0040
311 SKIN WARM 23 0.0039
312 PULMONARY CONGESTION 52 0.0039
313 MALNUTRITION 44 0.0039
314 URINE ODOUR ABNORMAL 23 0.0039
315 SELF-MEDICATION 16 0.0039
316 ANOREXIA 50 0.0039
317 INFUSION RELATED REACTION 257 0.0039
318 DIZZINESS 1920 0.0038
319 ANXIETY 1090 0.0038
320 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 26 0.0038
321 PARTIAL SEIZURES 20 0.0038
322 BRAIN OEDEMA 48 0.0038
323 SKIN IRRITATION 174 0.0038
324 STOMATITIS 230 0.0038
325 PRODUCTIVE COUGH 181 0.0038
326 WRONG TECHNIQUE IN DRUG USAGE PROCESS 137 0.0038
327 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
328 SKIN REACTION 53 0.0038
329 MALAISE 1648 0.0038
330 SPINAL OSTEOARTHRITIS 33 0.0038
331 TOXICITY TO VARIOUS AGENTS 633 0.0038
332 DYSLIPIDAEMIA 19 0.0037
333 MIOSIS 30 0.0037
334 TEARFULNESS 16 0.0037
335 SCHIZOPHRENIA 45 0.0037
336 ERUCTATION 71 0.0037
337 HYPERHIDROSIS 471 0.0037
338 MIDDLE INSOMNIA 68 0.0036
339 DRY THROAT 37 0.0036
340 PRODUCT PHYSICAL CONSISTENCY ISSUE 20 0.0036
341 DRUG DEPENDENCE 581 0.0036
342 SKIN ABRASION 17 0.0036
343 GINGIVAL BLEEDING 49 0.0036
344 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
345 PULMONARY OEDEMA 160 0.0036
346 AFFECTIVE DISORDER 28 0.0036
347 CARDIAC FLUTTER 23 0.0036
348 UNDERDOSE 258 0.0035
349 HYPOAESTHESIA ORAL 53 0.0035
350 TREMOR 578 0.0035
351 EXERCISE TOLERANCE DECREASED 20 0.0035
352 MOUTH SWELLING 20 0.0035
353 UNRESPONSIVE TO STIMULI 89 0.0034
354 ELECTROCARDIOGRAM ABNORMAL 27 0.0034
355 THROAT TIGHTNESS 93 0.0034
356 MYOCLONUS 41 0.0034
357 SLEEP DISORDER 242 0.0034
358 HYPOVOLAEMIA 20 0.0034
359 CARDIOMEGALY 42 0.0034
360 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 21 0.0034
361 RASH GENERALISED 88 0.0034
362 FEELING ABNORMAL 813 0.0034
363 TOOTH LOSS 70 0.0034
364 DYSPNOEA EXERTIONAL 127 0.0034
365 GESTATIONAL DIABETES 16 0.0034
366 SLEEP APNOEA SYNDROME 64 0.0034
367 HYPOXIA 118 0.0033
368 TOOTH ABSCESS 34 0.0033
369 MULTIPLE INJURIES 21 0.0033
370 INTENTIONAL PRODUCT MISUSE 291 0.0033
371 SCRATCH 35 0.0033
372 OROPHARYNGEAL PAIN 307 0.0033
373 STILLBIRTH 16 0.0033
374 MENTAL STATUS CHANGES 91 0.0033
375 RENAL CYST 26 0.0033
376 MITRAL VALVE INCOMPETENCE 37 0.0033
377 PARANOIA 56 0.0032
378 FLATULENCE 184 0.0032
379 SENSORY DISTURBANCE 52 0.0032
380 FEELING DRUNK 24 0.0032
381 CHOKING 63 0.0032
382 APHTHOUS ULCER 25 0.0032
383 CRYING 117 0.0032
384 PAIN IN JAW 91 0.0032
385 DEPENDENCE 176 0.0032
386 AGITATION 233 0.0032
387 MOOD SWINGS 101 0.0032
388 VISUAL DISTURBANCE 18 0.0031
389 EXPOSURE DURING PREGNANCY 194 0.0031
390 CHEST PAIN 577 0.0031
391 DRUG WITHDRAWAL SYNDROME 272 0.0031
392 HEART RATE IRREGULAR 70 0.0031
393 PSYCHOTIC DISORDER 91 0.0031
394 SUICIDAL IDEATION 282 0.0031
395 DRUG DIVERSION 19 0.0031
396 RENAL TUBULAR NECROSIS 30 0.0031
397 DEPRESSED MOOD 161 0.0030
398 DROOLING 21 0.0030
399 ERYTHEMA 624 0.0030
400 BURNING SENSATION 212 0.0030
401 TRICUSPID VALVE INCOMPETENCE 24 0.0030
402 PRODUCT DOSE OMISSION 197 0.0030
403 DRY MOUTH 243 0.0030
404 MYOCARDITIS 34 0.0030
405 SKIN PLAQUE 25 0.0030
406 THINKING ABNORMAL 55 0.0029
407 GASTROOESOPHAGEAL REFLUX DISEASE 236 0.0029
408 NEUTROPHIL COUNT INCREASED 30 0.0029
409 CONCOMITANT DISEASE AGGRAVATED 18 0.0029
410 ACUTE RESPIRATORY FAILURE 56 0.0029
411 DRUG EXPOSURE DURING PREGNANCY 99 0.0029
412 DRUG LEVEL INCREASED 48 0.0029
413 SCAB 33 0.0029
414 CHEST DISCOMFORT 296 0.0029
415 SKIN LACERATION 31 0.0028
416 MOUTH ULCERATION 60 0.0028
417 HEPATIC STEATOSIS 53 0.0028
418 TOOTH DISORDER 63 0.0028
419 DISTURBANCE IN ATTENTION 152 0.0028
420 HALLUCINATION 212 0.0028
421 SEROTONIN SYNDROME 54 0.0028
422 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
423 LOSS OF CONSCIOUSNESS 359 0.0028
424 ARTERIAL OCCLUSIVE DISEASE 22 0.0028
425 INGUINAL HERNIA 17 0.0028
426 NERVE INJURY 31 0.0028
427 DIZZINESS POSTURAL 27 0.0028
428 CARDIAC MURMUR 24 0.0028
429 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
430 DRUG INTERACTION 436 0.0027
431 ISCHAEMIC STROKE 49 0.0027
432 SOMNAMBULISM 18 0.0027
433 FEELING HOT 168 0.0027
434 PHARMACEUTICAL PRODUCT COMPLAINT 71 0.0027
435 CONVULSION 156 0.0027
436 ORTHOSTATIC HYPOTENSION 47 0.0027
437 VOMITING 1268 0.0027
438 DISORIENTATION 106 0.0027
439 DIVERTICULUM 19 0.0027
440 ANGINA PECTORIS 76 0.0026
441 HEPATITIS C 32 0.0026
442 HEADACHE 1659 0.0026
443 MENTAL IMPAIRMENT 64 0.0026
444 CONSTIPATION 575 0.0026
445 POISONING 33 0.0026
446 RESPIRATORY DISTRESS 72 0.0026
447 FEAR 70 0.0026
448 SEDATION 68 0.0026
449 DELIRIUM 90 0.0026
450 OBESITY 41 0.0026
451 SWOLLEN TONGUE 80 0.0026
452 DEPRESSION 582 0.0026
453 MANIA 42 0.0026
454 DYSARTHRIA 96 0.0025
455 PRODUCT PACKAGING ISSUE 24 0.0025
456 ACUTE KIDNEY INJURY 386 0.0025
457 PAROSMIA 19 0.0025
458 SINUS CONGESTION 34 0.0025
459 PALLOR 68 0.0025
460 BLISTER 140 0.0025
461 ABDOMINAL DISCOMFORT 418 0.0025
462 RIB FRACTURE 51 0.0025
463 HIATUS HERNIA 32 0.0025
464 TACHYCARDIA 219 0.0025
465 MOOD ALTERED 67 0.0025
466 DECUBITUS ULCER 20 0.0025
467 LOSS OF LIBIDO 22 0.0024
468 LACERATION 23 0.0024
469 EATING DISORDER 52 0.0024
470 ABNORMAL FAECES 20 0.0024
471 UPPER GASTROINTESTINAL HAEMORRHAGE 41 0.0024
472 INCORRECT ROUTE OF DRUG ADMINISTRATION 87 0.0024
473 PAIN IN EXTREMITY 717 0.0024
474 BLOOD MAGNESIUM DECREASED 21 0.0024
475 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 173 0.0024
476 THERAPEUTIC RESPONSE UNEXPECTED 109 0.0024
477 AGGRESSION 121 0.0024
478 MYDRIASIS 31 0.0024
479 HALLUCINATION, VISUAL 51 0.0024
480 THIRST 43 0.0024
481 RESPIRATORY FAILURE 175 0.0024
482 SCAR 41 0.0024
483 RESPIRATORY ARREST 66 0.0024
484 PRODUCT USE ISSUE 449 0.0024
485 MENTAL DISORDER 103 0.0024
486 SENSORY LOSS 19 0.0024
487 CYANOSIS 37 0.0024
488 FRUSTRATION TOLERANCE DECREASED 19 0.0023
489 PHARYNGEAL SWELLING 23 0.0023
490 LOCAL SWELLING 41 0.0023
491 APATHY 34 0.0023
492 URTICARIA 390 0.0023
493 MOUTH HAEMORRHAGE 17 0.0023
494 HYPERAESTHESIA 19 0.0023
495 EMOTIONAL DISORDER 71 0.0023
496 HYPERSOMNIA 66 0.0023
497 BLOOD PRESSURE INCREASED 351 0.0023
498 HAEMOPTYSIS 64 0.0023
499 ACUTE CORONARY SYNDROME 19 0.0023
500 RENAL INJURY 68 0.0023
501 ABNORMAL BEHAVIOUR 90 0.0023
502 LUNG NEOPLASM MALIGNANT 93 0.0023
503 OSTEOPOROSIS 93 0.0023
504 NECK PAIN 126 0.0023
505 CORONARY ARTERY DISEASE 68 0.0022
506 PNEUMONIA ASPIRATION 56 0.0022
507 VASCULITIS 26 0.0022
508 PRODUCT PHYSICAL ISSUE 45 0.0022
509 SHOCK HAEMORRHAGIC 18 0.0022
510 HYPOKALAEMIA 102 0.0022
511 COUGH 618 0.0022
512 RESTLESS LEGS SYNDROME 40 0.0022
513 MYOCARDIAL ISCHAEMIA 25 0.0022
514 BRAIN INJURY 22 0.0022
515 ATAXIA 26 0.0022
516 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
517 BLINDNESS TRANSIENT 16 0.0022
518 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
519 MUSCLE TIGHTNESS 35 0.0022
520 SKIN DISORDER 72 0.0022
521 HUNGER 30 0.0022
522 BLOOD TRIGLYCERIDES INCREASED 38 0.0021
523 PLATELET COUNT INCREASED 28 0.0021
524 RASH MACULAR 75 0.0021
525 PARAESTHESIA 335 0.0021
526 MEDICATION ERROR 118 0.0021
527 BLOOD SODIUM DECREASED 40 0.0021
528 RESPIRATORY DEPRESSION 26 0.0021
529 FEELING COLD 59 0.0021
530 PRURITUS 814 0.0021
531 ANAL INCONTINENCE 19 0.0021
532 ASPIRATION 23 0.0021
533 LEUKOCYTOSIS 38 0.0021
534 ABDOMINAL DISTENSION 219 0.0021
535 CARDIOMYOPATHY 31 0.0021
536 RENAL FAILURE 277 0.0021
537 DYSPNOEA 1179 0.0021
538 INCONTINENCE 22 0.0021
539 INJURY 146 0.0021
540 HYPERCHOLESTEROLAEMIA 20 0.0021
541 ACUTE MYOCARDIAL INFARCTION 61 0.0021
542 ANKLE FRACTURE 32 0.0021
543 ELECTROLYTE IMBALANCE 24 0.0021
544 BONE LOSS 31 0.0021
545 COMPLETED SUICIDE 171 0.0020
546 OXYGEN SATURATION DECREASED 115 0.0020
547 PERSONALITY CHANGE 19 0.0020
548 ABDOMINAL PAIN 475 0.0020
549 CONFUSIONAL STATE 329 0.0020
550 MUSCULOSKELETAL DISCOMFORT 35 0.0020
551 FLANK PAIN 19 0.0020
552 ILL-DEFINED DISORDER 122 0.0020
553 CELLULITIS 101 0.0020
554 ABDOMINAL PAIN UPPER 412 0.0020
555 BRONCHITIS 148 0.0020
556 RASH 871 0.0020
557 TACHYPNOEA 27 0.0020
558 HYPOAESTHESIA 296 0.0020
559 TOOTH INFECTION 26 0.0020
560 BLOOD POTASSIUM INCREASED 32 0.0020
561 HAEMATOCRIT DECREASED 39 0.0020
562 MUSCLE STRAIN 17 0.0020
563 LETHARGY 113 0.0020
564 SKIN SWELLING 17 0.0020
565 ASTHMA 221 0.0020
566 UROSEPSIS 18 0.0019
567 GRAND MAL CONVULSION 18 0.0019
568 EAR DISCOMFORT 20 0.0019
569 BONE DENSITY DECREASED 61 0.0019
570 ELECTROCARDIOGRAM QT PROLONGED 70 0.0019
571 HYPERKALAEMIA 68 0.0019
572 FIBROMYALGIA 47 0.0019
573 VENTRICULAR EXTRASYSTOLES 20 0.0019
574 LACRIMATION INCREASED 58 0.0019
575 TENDERNESS 20 0.0019
576 EMOTIONAL DISTRESS 232 0.0019
577 ANAEMIA 363 0.0019
578 FOOT FRACTURE 36 0.0019
579 AGEUSIA 47 0.0019
580 CIRCULATORY COLLAPSE 32 0.0019
581 VENTRICULAR TACHYCARDIA 31 0.0019
582 DEPRESSED LEVEL OF CONSCIOUSNESS 74 0.0019
583 AFFECT LABILITY 18 0.0019
584 COMA 89 0.0019
585 SOMNOLENCE 376 0.0019
586 INCORRECT DOSE ADMINISTERED 426 0.0019
587 MUSCLE TWITCHING 43 0.0019
588 DYSPHONIA 109 0.0019
589 PRESCRIBED OVERDOSE 36 0.0019
590 SKIN LESION 51 0.0019
591 HAEMATEMESIS 47 0.0019
592 BACTERAEMIA 22 0.0019
593 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
594 BRAIN NEOPLASM 17 0.0018
595 WEIGHT DECREASED 516 0.0018
596 IMPAIRED DRIVING ABILITY 21 0.0018
597 VITAMIN D DEFICIENCY 18 0.0018
598 RESPIRATORY DISORDER 55 0.0018
599 HYPERTENSION 389 0.0018
600 CARDIAC ARREST 151 0.0018
601 CORONARY ARTERY OCCLUSION 25 0.0018
602 SKIN ULCER 47 0.0018
603 GASTROINTESTINAL PAIN 20 0.0018
604 PHOTOSENSITIVITY REACTION 30 0.0018
605 C-REACTIVE PROTEIN INCREASED 66 0.0018
606 SPEECH DISORDER 95 0.0018
607 LUNG INFILTRATION 16 0.0018
608 LYMPHOCYTE COUNT DECREASED 32 0.0018
609 BLOOD PRESSURE DECREASED 120 0.0018
610 WEIGHT INCREASED 404 0.0018
611 BLOOD CHOLESTEROL INCREASED 84 0.0018
612 BLOOD PRESSURE SYSTOLIC INCREASED 35 0.0018
613 MYOCARDIAL INFARCTION 313 0.0018
614 FACIAL PAIN 16 0.0018
615 QUALITY OF LIFE DECREASED 24 0.0018
616 SKIN DISCOLOURATION 82 0.0018
617 INTERVERTEBRAL DISC PROTRUSION 39 0.0018
618 SWELLING FACE 116 0.0018
619 PANCREATITIS ACUTE 40 0.0018
620 ABORTION SPONTANEOUS 71 0.0018
621 BLOOD CREATINE PHOSPHOKINASE INCREASED 51 0.0018
622 CARDIO-RESPIRATORY ARREST 74 0.0018
623 PNEUMOTHORAX 28 0.0018
624 DECREASED ACTIVITY 19 0.0018
625 MIGRAINE 168 0.0018
626 RASH PRURITIC 95 0.0018
627 ENCEPHALOPATHY 43 0.0017
628 DERMATITIS ALLERGIC 22 0.0017
629 LIP SWELLING 58 0.0017
630 ASTHENIA 649 0.0017
631 INTENTIONAL PRODUCT USE ISSUE 151 0.0017
632 HOSPICE CARE 17 0.0017
633 PRODUCT ODOUR ABNORMAL 18 0.0017
634 CONTRAINDICATED PRODUCT ADMINISTERED 52 0.0017
635 NEPHROPATHY 16 0.0017
636 OSTEOMYELITIS 31 0.0017
637 HEMIPARESIS 29 0.0017
638 FAECES DISCOLOURED 37 0.0017
639 HEAD INJURY 54 0.0017
640 SMALL INTESTINAL OBSTRUCTION 21 0.0017
641 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
642 RENAL PAIN 18 0.0017
643 ROAD TRAFFIC ACCIDENT 71 0.0017
644 PHARYNGITIS 21 0.0017
645 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 31 0.0017
646 GASTRIC DISORDER 58 0.0017
647 NASAL CONGESTION 99 0.0017
648 HYPOTHERMIA 17 0.0017
649 DIABETES MELLITUS 128 0.0017
650 EJECTION FRACTION DECREASED 26 0.0017
651 INTENTIONAL OVERDOSE 107 0.0017
652 RASH MACULO-PAPULAR 37 0.0017
653 SEPTIC SHOCK 72 0.0017
654 RASH PAPULAR 37 0.0016
655 PREGNANCY 33 0.0016
656 NOCTURIA 20 0.0016
657 HYPERGLYCAEMIA 60 0.0016
658 EAR PAIN 32 0.0016
659 CARPAL TUNNEL SYNDROME 23 0.0016
660 IMPAIRED WORK ABILITY 35 0.0016
661 LUNG DISORDER 80 0.0016
662 HEPATOMEGALY 16 0.0016
663 SEASONAL ALLERGY 23 0.0016
664 OEDEMA PERIPHERAL 197 0.0016
665 CARDIOVASCULAR DISORDER 41 0.0016
666 NIGHT SWEATS 52 0.0016
667 SYNCOPE 161 0.0016
668 FACE OEDEMA 27 0.0016
669 HEART RATE DECREASED 56 0.0016
670 DRUG DOSE OMISSION 263 0.0016
671 PRODUCT USE COMPLAINT 25 0.0016
672 LIMB DISCOMFORT 49 0.0016
673 BLOOD COUNT ABNORMAL 24 0.0016
674 PRODUCT AVAILABILITY ISSUE 36 0.0016
675 SEIZURE 182 0.0016
676 DISCOMFORT 96 0.0016
677 MYALGIA 267 0.0016
678 BURSITIS 19 0.0016
679 SINUS DISORDER 31 0.0016
680 PAIN 953 0.0015
681 PULMONARY EMBOLISM 147 0.0015
682 PYREXIA 535 0.0015
683 MUSCULOSKELETAL PAIN 81 0.0015
684 EYE DISCHARGE 16 0.0015
685 HAEMORRHOIDS 30 0.0015
686 GENERALISED OEDEMA 19 0.0015
687 INTENTIONAL SELF-INJURY 31 0.0015
688 PERIPHERAL COLDNESS 21 0.0015
689 PLEURAL EFFUSION 93 0.0015
690 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
691 HOT FLUSH 115 0.0015
692 PRESYNCOPE 37 0.0015
693 DRUG INTOLERANCE 147 0.0015
694 BEDRIDDEN 20 0.0015
695 TYPE 2 DIABETES MELLITUS 51 0.0015
696 RENAL FAILURE ACUTE 64 0.0015
697 HYPOTENSION 302 0.0015
698 MUSCLE RIGIDITY 18 0.0015
699 APHONIA 21 0.0015
700 MUSCLE ATROPHY 19 0.0015
701 SUICIDE ATTEMPT 90 0.0015
702 ROTATOR CUFF SYNDROME 19 0.0015
703 NEOPLASM 17 0.0015
704 HYPONATRAEMIA 83 0.0015
705 PERICARDIAL EFFUSION 34 0.0015
706 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 265 0.0015
707 AKATHISIA 20 0.0015
708 MULTIPLE FRACTURES 24 0.0015
709 PRODUCT PREPARATION ERROR 30 0.0015
710 WHITE BLOOD CELL COUNT INCREASED 56 0.0015
711 ADVERSE DRUG REACTION 131 0.0015
712 BLOOD CREATININE INCREASED 95 0.0015
713 ERECTILE DYSFUNCTION 37 0.0014
714 COAGULOPATHY 24 0.0014
715 MASS 20 0.0014
716 BLOOD POTASSIUM DECREASED 43 0.0014
717 CHOLECYSTITIS 17 0.0014
718 EYE SWELLING 53 0.0014
719 RASH ERYTHEMATOUS 68 0.0014
720 BODY TEMPERATURE INCREASED 29 0.0014
721 SWELLING 133 0.0014
722 WRIST FRACTURE 17 0.0014
723 DISABILITY 28 0.0014
724 AMNESIA 92 0.0014
725 BACK PAIN 328 0.0014
726 ANAPHYLACTIC REACTION 78 0.0014
727 METABOLIC ACIDOSIS 45 0.0014
728 LOWER LIMB FRACTURE 27 0.0014
729 DRUG PRESCRIBING ERROR 27 0.0014
730 JOINT INJURY 30 0.0014
731 DYSSTASIA 41 0.0014
732 ADRENAL INSUFFICIENCY 17 0.0014
733 CARDIOGENIC SHOCK 20 0.0014
734 TRANSIENT ISCHAEMIC ATTACK 47 0.0014
735 PRODUCT ADMINISTRATION ERROR 28 0.0014
736 HYPERCALCAEMIA 17 0.0014
737 FEBRILE NEUTROPENIA 91 0.0014
738 MOVEMENT DISORDER 44 0.0014
739 OSTEOARTHRITIS 58 0.0014
740 GASTRITIS 36 0.0014
741 GASTROINTESTINAL HAEMORRHAGE 114 0.0014
742 ILLNESS 140 0.0014
743 DYSURIA 50 0.0014
744 DEHYDRATION 181 0.0014
745 UPPER LIMB FRACTURE 27 0.0014
746 DELUSION 21 0.0014
747 DRUG EFFECT INCOMPLETE 49 0.0013
748 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
749 SINUSITIS 138 0.0013
750 PULMONARY HYPERTENSION 28 0.0013
751 DEEP VEIN THROMBOSIS 87 0.0013
752 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64 0.0013
753 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 45 0.0013
754 RHINORRHOEA 86 0.0013
755 BALANCE DISORDER 115 0.0013
756 PARALYSIS 19 0.0013
757 LIMB INJURY 36 0.0013
758 WOUND 37 0.0013
759 PNEUMONITIS 36 0.0013
760 IMPAIRED GASTRIC EMPTYING 18 0.0013
761 ULCER 21 0.0013
762 PNEUMONIA 427 0.0013
763 GASTRIC ULCER 25 0.0013
764 HYPOTHYROIDISM 42 0.0013
765 VERTIGO 80 0.0013
766 CHOLELITHIASIS 43 0.0013
767 HYPOKINESIA 19 0.0013
768 LIVER FUNCTION TEST ABNORMAL 38 0.0013
769 SHOCK 30 0.0013
770 GASTROENTERITIS 19 0.0013
771 LYMPHADENOPATHY 46 0.0013
772 HEAD DISCOMFORT 23 0.0013
773 EPISTAXIS 96 0.0013
774 DECREASED APPETITE 298 0.0013
775 SEPSIS 143 0.0013
776 CEREBROVASCULAR ACCIDENT 217 0.0013
777 ADVERSE EVENT 118 0.0013
778 HYPOGLYCAEMIA 62 0.0013
779 KIDNEY INFECTION 25 0.0013
780 INTESTINAL OBSTRUCTION 48 0.0013
781 NEUTROPENIA 173 0.0013
782 DIPLOPIA 33 0.0013
783 CONDITION AGGRAVATED 386 0.0013
784 VISION BLURRED 174 0.0013
785 JAUNDICE 34 0.0013
786 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 37 0.0013
787 DIVERTICULITIS 35 0.0013
788 BRONCHOSPASM 18 0.0013
789 SUBDURAL HAEMATOMA 18 0.0013
790 IMPAIRED QUALITY OF LIFE 18 0.0013
791 INFUSION SITE PAIN 16 0.0012
792 DERMATITIS 26 0.0012
793 CHROMATURIA 28 0.0012
794 OEDEMA 67 0.0012
795 BACK DISORDER 20 0.0012
796 ABDOMINAL PAIN LOWER 31 0.0012
797 RHABDOMYOLYSIS 51 0.0012
798 ACCIDENTAL EXPOSURE TO PRODUCT 125 0.0012
799 BLOOD PRESSURE FLUCTUATION 29 0.0012
800 BRADYCARDIA 64 0.0012
801 ADVERSE REACTION 16 0.0012
802 SKIN BURNING SENSATION 86 0.0012
803 RESPIRATORY TRACT CONGESTION 19 0.0012
804 BLOOD UREA INCREASED 20 0.0012
805 INTERNATIONAL NORMALISED RATIO INCREASED 34 0.0012
806 FALL 396 0.0012
807 CEREBRAL INFARCTION 29 0.0012
808 DIARRHOEA 762 0.0012
809 ACUTE HEPATIC FAILURE 16 0.0012
810 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
811 MUSCLE SPASMS 212 0.0012
812 TINNITUS 53 0.0012
813 BONE DISORDER 21 0.0012
814 STAPHYLOCOCCAL INFECTION 38 0.0012
815 BLOOD GLUCOSE INCREASED 217 0.0012
816 UPPER RESPIRATORY TRACT INFECTION 53 0.0011
817 EPILEPSY 35 0.0011
818 EOSINOPHILIA 20 0.0011
819 FATIGUE 880 0.0011
820 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
821 PRODUCT SUBSTITUTION ISSUE 65 0.0011
822 HIP FRACTURE 36 0.0011
823 IRRITABLE BOWEL SYNDROME 24 0.0011
824 CHILLS 131 0.0011
825 DYSPHAGIA 106 0.0011
826 PANCREATITIS 59 0.0011
827 DEAFNESS 29 0.0011
828 ANGIOEDEMA 49 0.0011
829 VAGINAL HAEMORRHAGE 48 0.0011
830 ANOSMIA 16 0.0011
831 POLLAKIURIA 46 0.0011
832 CONTUSION 106 0.0011
833 MULTI-ORGAN FAILURE 19 0.0011
834 CYTOKINE RELEASE SYNDROME 22 0.0011
835 DRUG EFFECT DECREASED 59 0.0011
836 EXTRA DOSE ADMINISTERED 44 0.0011
837 DIABETIC KETOACIDOSIS 26 0.0011
838 INFLUENZA 120 0.0011
839 BONE PAIN 63 0.0011
840 DIABETES MELLITUS INADEQUATE CONTROL 19 0.0011
841 THERAPEUTIC PRODUCT EFFECT DECREASED 48 0.0011
842 CARDIAC FAILURE CONGESTIVE 86 0.0011
843 GAIT DISTURBANCE 204 0.0011
844 MEMORY IMPAIRMENT 146 0.0011
845 DYSKINESIA 43 0.0011
846 BLOOD PRESSURE ABNORMAL 21 0.0011
847 HAEMOGLOBIN DECREASED 108 0.0011
848 DEVICE FAILURE 16 0.0010
849 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0010
850 URINARY RETENTION 35 0.0010
851 URINARY INCONTINENCE 31 0.0010
852 FEEDING DISORDER 21 0.0010
853 THROMBOSIS 83 0.0010
854 HOSPITALISATION 158 0.0010
855 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
856 PERIPHERAL SWELLING 158 0.0010
857 HAEMATURIA 35 0.0010
858 MUSCULAR WEAKNESS 116 0.0010
859 LIVER INJURY 25 0.0010
860 MUCOSAL INFLAMMATION 26 0.0010
861 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
862 OCULAR HYPERAEMIA 47 0.0010
863 CHOLESTASIS 19 0.0010
864 TRANSAMINASES INCREASED 22 0.0010
865 SURGERY 58 0.0010
866 COGNITIVE DISORDER 46 0.0010
867 EAR INFECTION 26 0.0010
868 CYSTITIS 31 0.0010
869 INFLUENZA LIKE ILLNESS 80 0.0010
870 BLOOD BILIRUBIN INCREASED 26 0.0010
871 CARDIAC DISORDER 90 0.0010
872 HEPATIC FAILURE 29 0.0010
873 APHASIA 29 0.0010
874 CARDIAC FAILURE 77 0.0010
875 SPINAL FRACTURE 19 0.0009
876 PROTEINURIA 18 0.0009
877 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
878 OFF LABEL USE 823 0.0009
879 PULMONARY FIBROSIS 18 0.0009
880 NERVOUS SYSTEM DISORDER 29 0.0009
881 PRODUCT USE IN UNAPPROVED INDICATION 230 0.0009
882 DYSTONIA 18 0.0009
883 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
884 ATRIAL FIBRILLATION 90 0.0009
885 LEUKOPENIA 46 0.0009
886 RED BLOOD CELL COUNT DECREASED 26 0.0009
887 URINARY TRACT INFECTION 155 0.0009
888 HEPATIC CIRRHOSIS 17 0.0009
889 THROMBOCYTOPENIA 101 0.0009
890 MUSCULOSKELETAL STIFFNESS 79 0.0009
891 LACTIC ACIDOSIS 29 0.0009
892 ARRHYTHMIA 42 0.0009
893 GASTROENTERITIS VIRAL 16 0.0009
894 POST PROCEDURAL COMPLICATION 17 0.0009
895 RESPIRATORY TRACT INFECTION 23 0.0009
896 HYPOACUSIS 38 0.0009
897 EYE DISORDER 29 0.0009
898 HERNIA 17 0.0009
899 JOINT STIFFNESS 23 0.0009
900 ARTHRALGIA 360 0.0009
901 FLUID RETENTION 44 0.0009
902 BACTERIAL INFECTION 16 0.0009
903 NEUROPATHY PERIPHERAL 81 0.0009
904 NEPHROLITHIASIS 39 0.0008
905 ABASIA 21 0.0008
906 HAEMATOMA 22 0.0008
907 BLOOD URINE PRESENT 16 0.0008
908 VIRAL INFECTION 28 0.0008
909 THERAPY CESSATION 43 0.0008
910 BONE MARROW FAILURE 17 0.0008
911 HYPOPHAGIA 21 0.0008
912 GENERAL PHYSICAL HEALTH DETERIORATION 94 0.0008
913 CEREBRAL HAEMORRHAGE 29 0.0008
914 OSTEONECROSIS OF JAW 20 0.0008
915 EXTRAPYRAMIDAL DISORDER 20 0.0008
916 PRODUCT DISPENSING ERROR 17 0.0008
917 LABORATORY TEST ABNORMAL 23 0.0008
918 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
919 VISUAL IMPAIRMENT 96 0.0008
920 STEVENS-JOHNSON SYNDROME 17 0.0008
921 RENAL DISORDER 35 0.0008
922 FUNGAL INFECTION 25 0.0007
923 RENAL IMPAIRMENT 63 0.0007
924 NEOPLASM MALIGNANT 50 0.0007
925 JOINT SWELLING 90 0.0007
926 EYE PRURITUS 25 0.0007
927 NASOPHARYNGITIS 137 0.0007
928 PRODUCT PRESCRIBING ISSUE 16 0.0007
929 BLOOD GLUCOSE DECREASED 35 0.0007
930 UNEVALUABLE EVENT 55 0.0007
931 MOBILITY DECREASED 52 0.0007
932 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
933 SKIN EXFOLIATION 60 0.0007
934 TARDIVE DYSKINESIA 20 0.0007
935 LOCALISED INFECTION 17 0.0007
936 INTENTIONAL DOSE OMISSION 20 0.0007
937 NEURALGIA 17 0.0007
938 FLUSHING 70 0.0007
939 PRODUCT DOSE OMISSION ISSUE 202 0.0007
940 ARTHRITIS 54 0.0007
941 THERAPEUTIC RESPONSE DECREASED 41 0.0007
942 OSTEONECROSIS 22 0.0007
943 GASTROINTESTINAL DISORDER 60 0.0007
944 NEUTROPHIL COUNT DECREASED 27 0.0007
945 DRY EYE 33 0.0007
946 HAEMORRHAGE 69 0.0007
947 ASPARTATE AMINOTRANSFERASE INCREASED 35 0.0007
948 FEMUR FRACTURE 20 0.0006
949 MULTIPLE SCLEROSIS RELAPSE 44 0.0006
950 IMPAIRED HEALING 21 0.0006
951 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
952 HEPATIC ENZYME INCREASED 43 0.0006
953 MULTIPLE SCLEROSIS 30 0.0006
954 INFLAMMATION 32 0.0006
955 BLINDNESS 25 0.0006
956 NO ADVERSE EVENT 111 0.0006
957 ECZEMA 32 0.0006
958 PANCYTOPENIA 34 0.0006
959 INFECTION 87 0.0006
960 DRY SKIN 79 0.0006
961 THERAPY NON-RESPONDER 26 0.0006
962 ASCITES 17 0.0006
963 ARTHROPATHY 31 0.0006
964 PLATELET COUNT DECREASED 59 0.0006
965 VISUAL ACUITY REDUCED 17 0.0005
966 GAIT INABILITY 17 0.0005
967 DISEASE PROGRESSION 59 0.0005
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 23 0.0005
969 WHITE BLOOD CELL COUNT DECREASED 53 0.0005
970 ALOPECIA 96 0.0005
971 EYE PAIN 27 0.0005
972 LIVER DISORDER 21 0.0005
973 CATARACT 28 0.0005
974 HERPES ZOSTER 27 0.0005
975 MALIGNANT NEOPLASM PROGRESSION 47 0.0005
976 DEATH 381 0.0004
977 DISEASE RECURRENCE 21 0.0004
978 THERAPY INTERRUPTED 31 0.0004
979 ACNE 31 0.0004
980 EYE IRRITATION 23 0.0004
981 PSORIASIS 49 0.0004
982 COVID-19 64 0.0004
983 RHEUMATOID ARTHRITIS 36 0.0003
984 DEVICE ISSUE 25 0.0003
985 INJECTION SITE REACTION 19 0.0003
986 INJECTION SITE PRURITUS 18 0.0003
987 PRODUCT STORAGE ERROR 22 0.0003
988 TREATMENT FAILURE 20 0.0002
989 INJECTION SITE PAIN 74 0.0002
990 DEVICE MALFUNCTION 16 0.0002
991 BREAST CANCER 20 0.0002
992 INJECTION SITE ERYTHEMA 20 0.0002